Key risk factors of early-onset Alzheimer’s disease

Credit: Unsplash+

Alzheimer’s disease is commonly associated with older adults, typically affecting those over the age of 65. However, early-onset Alzheimer’s disease (EOAD), which occurs in individuals under the age of 65, presents a unique and particularly challenging aspect of this cognitive disorder.

Despite its relative rarity, affecting only about 5% of all Alzheimer’s patients, understanding the risk factors for EOAD is crucial for early detection and potential prevention.

This article breaks down the current understanding of what may contribute to the risk of developing early-onset Alzheimer’s.

Genetic Factors: Genetics play a significant role in early-onset Alzheimer’s. Unlike the more common late-onset Alzheimer’s, which has a more complex and less understood set of genetic and environmental influences, EOAD often has a stronger link to specific genetic mutations.

Mutations in one of three genes—presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein (APP)—are known to significantly increase the risk.

These genes are involved in the production of amyloid-beta peptides, which accumulate abnormally in Alzheimer’s and form the characteristic plaques in the brain.

If a parent carries a mutation in any of these genes, their children have a 50% chance of inheriting the mutation and potentially developing EOAD. Genetic testing can identify these mutations, which is especially important for families with a history of early-onset Alzheimer’s.

Family History: Having a family history of Alzheimer’s, especially EOAD, is a major risk factor. Individuals with a first-degree relative (parent or sibling) who developed EOAD are at a higher risk of developing the disease themselves.

This risk increases if more than one family member has been affected by EOAD. While not all cases of early-onset Alzheimer’s are linked to the known genetic mutations, familial patterns strongly suggest a genetic component.

Down Syndrome: Individuals with Down syndrome are at a higher risk of developing early-onset Alzheimer’s.

Due to having three copies of chromosome 21 (trisomy 21), individuals with Down syndrome produce extra amyloid precursor protein, which leads to the earlier development of amyloid plaques.

Studies indicate that by the age of 40, nearly all individuals with Down syndrome have these plaques, although not all develop Alzheimer’s symptoms.

Head Injuries: Research has also shown a correlation between severe head injuries and an increased risk of Alzheimer’s, including EOAD.

Head injuries that result in loss of consciousness may disrupt brain function and structure, potentially accelerating the Alzheimer’s disease process, especially in those with a genetic predisposition.

Lifestyle Factors: While lifestyle factors are more commonly associated with late-onset Alzheimer’s, they can also influence the risk of EOAD.

Cardiovascular risk factors such as obesity, diabetes, high blood pressure, and high cholesterol may contribute to the development of Alzheimer’s disease at an earlier age. A healthy diet, regular physical activity, and managing cardiovascular health can potentially reduce the risk.

In conclusion, early-onset Alzheimer’s disease, while less common than its late-onset counterpart, presents a significant health challenge, heavily influenced by genetic factors. Understanding these risk factors is crucial for early diagnosis and intervention.

For those with a family history or genetic predisposition to EOAD, genetic counseling and regular medical check-ups may help manage the risk. Meanwhile, maintaining a healthy lifestyle could play a role in mitigating some of the modifiable risk factors.

As research continues to evolve, it is hoped that more definitive prevention strategies will become available, offering hope to those at risk of this debilitating disease.

If you care about Alzheimer’s disease, please read studies that bad lifestyle habits can cause Alzheimer’s disease, and strawberries can be good defence against Alzheimer’s.

For more information about brain health, please see recent studies that oral cannabis extract may help reduce Alzheimer’s symptoms, and Vitamin E may help prevent Parkinson’s disease.

Copyright © 2024 Knowridge Science Report. All rights reserved.